Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erhuang Decoction for radiation-induced skin damage after tumor radiotherapy
ChiCTR-TRC-13003623Phase 3Completed
- Sponsor
- China Academy of Chinese Medical Sciences
- Start
- Jan 2013
- Countries
- 1
01
Overview
Phase 3, open-label trial of erhuang decoction in radiodermatitis (2 arms), sponsored by China Academy of Chinese Medical Sciences. Primary endpoint: Radiation-induced skin damage grading. Started Jan 2013; status: completed.
02
Drugs
erhuang decoction
03
Conditions
radiodermatitis
Beyond the preview
Go deeper on ChiCTR-TRC-13003623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003623.